In agree with above views, administration of UDCA supplied with GSH to the child patient significantly improved her liver function (Fig 3), because this treatment can recover the expression/function of Bsep and Mrp2 and mitigate hepatic inflammation in cholestasis (Kagawa et al, 2014; Gonzales et al, 2015). This evidence concerns the gene ABCC2 and cholestasis.